Document Detail


Changes in quality of life scores with intravenous immunoglobulin or plasmapheresis in patients with myasthenia gravis.
MedLine Citation:
PMID:  23154126     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Intravenous immunoglobulin (IVIG) and plasmapheresis (plasma exchange (PLEX)) have comparable efficacy in reducing the Quantitative Myasthenia Gravis Score for disease severity (QMGS) in patients with moderate to severe myasthenia gravis (MG). OBJECTIVE: To determine if the improvement in the quality of life (QOL) after immunomodulation is comparable with either IVIG or PLEX. METHODS: 62 patients participated in the MG-QOL-60 study, completing the questionnaire at baseline and at day 14 after treatment. The MG-QOL-15 scores were computed from the MG-QOL-60 questionnaire responses. We analysed the change in the QOL scores from baseline to day 14 in both treatment groups. RESULTS: The scores in both QOL scales decreased at day 14 in the IVIG and PLEX groups, without significant difference between groups (QOL-15: IVIG -5.7±8.5, PLEX: -7.0±7.6, p=0.52; QOL-60: IVIG -13.3±16.9, PLEX -18.5±22.0, p=0.41). The improvement in QOL showed a good correlation with the decrease in QMGS. There was an excellent correlation between the MG-QOL-15 and MG-QOL-60 scores at baseline and at day 14. CONCLUSIONS: This study of MG-QOL changes supports recent findings that IVIG and PLEX are comparable in the treatment of patients with moderate to severe MG and worsening symptoms. Furthermore, our study supports the use of the MG-QOL-15 as a secondary outcome measure in future clinical trials in MG.
Authors:
Carolina Barnett; Graham Wilson; David Barth; Hans D Katzberg; Vera Bril
Related Documents :
23593976 - Effect of orthodontic treatment on oral health-related quality of life.
24462856 - The use of a multimedia module to aid the informed consent process in patients undergoi...
24555576 - Do randomized clinical trials with inadequate blinding report enhanced placebo effects ...
20464636 - Using the short form-36 mental summary score as an indicator of depressive symptoms in ...
16500776 - Effects of a cognitive-behavioural internet program on depression, vulnerability to dep...
23750786 - Factor structure of the beck depression inventory-ii among south africans receiving ant...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-15
Journal Detail:
Title:  Journal of neurology, neurosurgery, and psychiatry     Volume:  -     ISSN:  1468-330X     ISO Abbreviation:  J. Neurol. Neurosurg. Psychiatr.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985191R     Medline TA:  J Neurol Neurosurg Psychiatry     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Medicine, Division of Neurology, Toronto General Hospital, , Toronto, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Deep brain stimulation for dystonia.
Next Document:  Modulation of the cellular redox status by the Alternaria toxins alternariol and alternariol monomet...